Related Experiment Video
Updated: May 1, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.8K
New drugs for HDL-C disorders: the beginning
MyNgan Duong, Stephen J Nicholls1
1South Australian Health and Medical Research Institute. PO Box 11060. Adelaide, SA, 5001, Australia. stephen.nicholls@sahmri.com.
Current Medicinal Chemistry
|April 17, 2014
Summary
Novel therapies targeting high-density lipoprotein cholesterol (HDL-C) have faced setbacks. This review examines ongoing investigations into agents affecting HDL quantity and quality, despite recent clinical trial controversies.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Biochemistry
Background:
- Significant research interest exists in developing therapies to increase high-density lipoprotein cholesterol (HDL-C) levels.
- Recent clinical trials investigating HDL-C-raising agents have yielded controversial results, questioning their therapeutic utility.
Purpose of the Study:
- To review current and emerging therapeutic agents aimed at modulating high-density lipoprotein cholesterol (HDL-C).
- To discuss the variable effects of these agents on HDL quantity and quality.
Main Methods:
- Literature review of ongoing investigations into novel HDL-C-raising therapies.
- Analysis of clinical trial outcomes and their implications for HDL-C as a therapeutic target.
Main Results:
- Despite decades of research, the clinical utility of raising HDL-C remains debated due to trial failures.
- Various classes of agents are under investigation, exhibiting diverse impacts on HDL characteristics.
Conclusions:
- The therapeutic strategy of increasing HDL-C levels requires careful consideration given recent clinical evidence.
- Further research is needed to understand the nuanced effects of different agents on HDL function and patient outcomes.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
01:26Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
01:26Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
01:30Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K